Koon Yew Yin's Blog

China COVID-19 white paper: An all-out effort to prevent and treat patients - Koon Yew Yin

Koon Yew Yin
Publish date: Sun, 07 Jun 2020, 03:57 PM
Koon Yew Yin
0 1,417
An official blog in i3investor to publish sharing by Mr. Koon Yew Yin.

All materials published here are prepared by Mr. Koon Yew Yin

7 June 2020

Currently US has 1.96 million confirmed Covid 19 cases and 111,000 deaths and these 2 figures are still increasing at an alarming rate. When US started to have Covid 19 cases, US President Trump said that the virus was made in China. Yes, like most Americans, Trump cannot go by a day without the use of products made in China.

Currently China has so few cases that can be countered with your fingers. That is why US President Trump does not believe China’s success in the prevention and cure of Covid 19 patients. China’s key to success is complete lockdown Wuhan, a city of 12 million people. After 76 days of lockdown, the city is open up again and people are moving about like before. China continues to improve its economy while US is still struggling with the increasing number of Covid 19 cases, jobless claims and riots in most cities. 

An old English saying “He who laughs last, laughs best”.  

But Trump cannot lockdown the whole country because the number of jobless claims is increasing to about 40 million, 1 in 5 people is out of work. Moreover, millions of people are joining the riots in most cities in America due to the killing of George Floyd by the police. Obviously, a US recession is invertible. To win more vote for the coming November election, Trump continues to bash China and most Americans like it.      

To clarify the misunderstanding China has just released a white paper for all to see.  

From early outbreak to an all-out nationwide effort to save as many lives as possible, the Chinese Government has taken the most comprehensive, the strictest and the most thorough prevention and control measures to combat the coronavirus outbreak, according to the white paper released by the State Council Information Office on Sunday.

The white paper, titled "Fighting COVID-19: China in Action," lists major actions and important lessons collected from the pandemic over the past several months.

Early at the outbreak

During the early stages of the outbreak, there were not enough hospital beds for the surging number of critical COVID-19 patients. So, making more beds available was the focus.

 

China achieved the miracle of building two large hospitals in just days and created more than 1,000 beds with medical capabilities in Wuhan, the then epicentre of the outbreak. And existing hospitals were enlarged to provide more beds.

The number of hospital beds in Wuhan increased from 1,000 to 9,100 to drastically reduce the waiting time by critically ill patients for treatment.

Interference for mild cases

Early treatment can limit the development of COVID-19. About 80 percent of patients only showed mild symptoms and didn't need ICU beds to recover early in the outbreak.

For these people, Wuhan turned 16 stadiums and exhibition halls into temporary medical centres, adding 13,000 more beds to put mild cases into quarantine. This greatly limited the long-term spread of the novel coronavirus.

Advanced technology, such as remote video diagnosis, was another special feature of China's plan for mild cases. With 5G and optic fibre, hospitals across China were linked together to form a nationwide network against the epidemic.

Up-to-date treatment plans

As an early battleground of the COVID-19 epidemic, China has issued seven evidence-based guidelines on coronavirus diagnosis and treatment, which have proven to be effective in global epidemic prevention and control.

Soon after the outbreak, Chinese experts have updated seven versions of the guidelines in less than two months to provide clinical staff with the latest effective methods in identifying, diagnosing and treating the disease, which had never been experienced in China before but with wide and quick infection rate.

Each version was updated with a better knowledge of the clinical manifestations and pathology of COVID-19, and has provided clinical medical personnel with efficient guidance.

TCM, a promising option 

Experts in China have opted for a combination of Traditional Chinese Medicine (TCM) and western medicines for COVID-19 patients, as both have strengths.

Data shows TCM has been used on more than 90 percent of China's COVID-19 patients. In Wuhan, the hardest-hit city, nearly all patients in temporary hospitals have been treated with TCM to increase recovery rates and lower mortality rates.

As the spread in other countries continues, Chinese doctors, who served on the front line in fighting against COVID-19 in Wuhan, share TCM information and experience with their international peers from around the world via video conferences.

Helping COVID-19 patients pay medical bills

China has updated its health insurance policy by adjusting that of confirmed and suspected COVID-19 patients who were provided with treatment first irrespective of cost issues.

For these medical costs, public finance provides subsidies for the deductible borne by individuals, while the rest is covered by basic medical insurance, critical illness insurance programs and medical assistance per their respective rules.

 

 

 

More articles on Koon Yew Yin's Blog
Sendai is under priced - Koon Yew Yin

Created by Koon Yew Yin | May 13, 2024

Eversendai Corporation Berhad recently reported its earnings results for the fourth quarter ended December 31, 2023. Here are the key financial highlights:

Eversendai Corporation made a remarkable comeback in FY2023 - Koon Yew Yin

Created by Koon Yew Yin | May 06, 2024

Eversendai Corporation Berhad made a remarkable comeback in FY2023, reporting strong profit growth. Here are the key highlights from their financial performance:

Sendai is still up trend - Koon Yew Yin

Created by Koon Yew Yin | Apr 30, 2024

As shown on the chart below, Sendai has been dropping in the last few days. Today all shareholders must be wondering to sell, hold on or to buy some at a cheaper price.

Eversendai Corporation made a remarkable comeback in FY2023 - Koon Yew Yin

Created by Koon Yew Yin | Apr 22, 2024

Eversendai Corporation Berhad made a remarkable comeback in FY2023, reporting strong profit growth. Here are the key highlights from their financial performance:

Sendai price trend reversal - Koon Yew Yin

Created by Koon Yew Yin | Apr 22, 2024

Sendai price chart below is showing its price trend reversal. It is hitting a record high.

How can KSL double its profit? - Koon Yew Yin

Created by Koon Yew Yin | Apr 18, 2024

After the stock closed yesterday, KSL announced its 4th quarter EPS which is 40.76 sen and its net tangible asset (NTA) backing of Rm 3.65. Its profit increased by 230% more than last year.

Why Sabah will leave Malaysia - Koon Yew Yin

Created by Koon Yew Yin | Mar 29, 2024

Currently Sabah Government does not know that solar panel produces the cheapest electricity???

Malaysia can be one of the richest nations in the world - Koon Yew Yin

Created by Koon Yew Yin | Mar 23, 2024

During my life time I saw every Prime Minister being replaced by another politician for one reason or another. Dr Mahathir managed to stay the longest time of 22 years.

Property Developers comparison - Koon Yew Yin

Created by Koon Yew Yin | Mar 04, 2024

All property developers have just announced their annual profit for 2023. All of them reported increased profit.

My contribution as an Engineer - Koon Yew Yin

Created by Koon Yew Yin | Mar 04, 2024

Although my writing of this article sounds boastful but I feel that it is important to keep this record for posterity. Engineers play a pivotal role in shaping our modern world.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment